Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy

Inhibition of vascular endothelial growth factor (VEGF) in retinopathy of prematurity (ROP) raises concerns for premature infants because VEGF is essential for retinovascular development as well as neuronal and glial health. This study tested the hypothesis that endothelial cell-specific knockdown o...

Descripción completa

Detalles Bibliográficos
Autores principales: Simmons, Aaron B., Bretz, Colin A., Wang, Haibo, Kunz, Eric, Hajj, Kassem, Kennedy, Carson, Yang, Zhihong, Suwanmanee, Thipparat, Kafri, Tal, Hartnett, M. Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203654/
https://www.ncbi.nlm.nih.gov/pubmed/29730824
http://dx.doi.org/10.1007/s10456-018-9618-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203654/
https://www.ncbi.nlm.nih.gov/pubmed/29730824
http://dx.doi.org/10.1007/s10456-018-9618-5

Ejemplares similares